116 related articles for article (PubMed ID: 12220512)
21. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
[TBL] [Abstract][Full Text] [Related]
22. Novel immunostimulatory phosphodiester oligodeoxynucleotides with CpT sequences instead of CpG motifs.
Kim D; Jung J; Lee Y; Kwon HJ
Mol Immunol; 2011 Jul; 48(12-13):1494-504. PubMed ID: 21529949
[TBL] [Abstract][Full Text] [Related]
23. Effects of a hexameric deoxyriboguanosine run conjugation into CpG oligodeoxynucleotides on their immunostimulatory potentials.
Lee SW; Song MK; Baek KH; Park Y; Kim JK; Lee CH; Cheong HK; Cheong C; Sung YC
J Immunol; 2000 Oct; 165(7):3631-9. PubMed ID: 11034366
[TBL] [Abstract][Full Text] [Related]
24. Oligodeoxynucleotides containing synthetic immunostimulatory motifs augment potent Th1 immune responses to HBsAg in mice.
Li Y; Kandimalla ER; Yu D; Agrawal S
Int Immunopharmacol; 2005 Jun; 5(6):981-91. PubMed ID: 15829414
[TBL] [Abstract][Full Text] [Related]
25. Immunostimulation and anti-DNA antibody production by backbone modified CpG-DNA.
Kim D; Rhee JW; Kwon S; Sohn WJ; Lee Y; Kim DW; Kim DS; Kwon HJ
Biochem Biophys Res Commun; 2009 Feb; 379(2):362-7. PubMed ID: 19103173
[TBL] [Abstract][Full Text] [Related]
26. Modulation of ovalbumin-induced Th2 responses by second-generation immunomodulatory oligonucleotides in mice.
Zhu FG; Kandimalla ER; Yu D; Tang JX; Agrawal S
Int Immunopharmacol; 2004 Jul; 4(7):851-62. PubMed ID: 15182725
[TBL] [Abstract][Full Text] [Related]
27. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
Gekeler V; Gimmnich P; Hofmann HP; Grebe C; Römmele M; Leja A; Baudler M; Benimetskaya L; Gonser B; Pieles U; Maier T; Wagner T; Sanders K; Beck JF; Hanauer G; Stein CA
Oligonucleotides; 2006; 16(1):83-93. PubMed ID: 16584297
[TBL] [Abstract][Full Text] [Related]
28. Agonists of Toll-like receptor 9 containing synthetic dinucleotide motifs.
Yu D; Putta MR; Bhagat L; Li Y; Zhu F; Wang D; Tang JX; Kandimalla ER; Agrawal S
J Med Chem; 2007 Dec; 50(25):6411-8. PubMed ID: 17988082
[TBL] [Abstract][Full Text] [Related]
29. Accessible 5'-end of CpG-containing phosphorothioate oligodeoxynucleotides is essential for immunostimulatory activity.
Yu D; Zhao Q; Kandimalla ER; Agrawal S
Bioorg Med Chem Lett; 2000 Dec; 10(23):2585-8. PubMed ID: 11128629
[TBL] [Abstract][Full Text] [Related]
30. Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen.
Tewary P; Sukumaran B; Saxena S; Madhubala R
Vaccine; 2004 Aug; 22(23-24):3053-60. PubMed ID: 15297055
[TBL] [Abstract][Full Text] [Related]
31. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS
Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938
[TBL] [Abstract][Full Text] [Related]
32. Efficient peritoneal dissemination treatment obtained by an immunostimulatory phosphorothioate-type CpG DNA/cationic liposome complex in mice.
Kuramoto Y; Kawakami S; Zhou S; Fukuda K; Yamashita F; Hashida M
J Control Release; 2008 Mar; 126(3):274-80. PubMed ID: 18237815
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of murine macrophage IL-12 production by natural and synthetic DNA.
Pisetsky DS; Reich CF
Clin Immunol; 2000 Sep; 96(3):198-204. PubMed ID: 10964537
[TBL] [Abstract][Full Text] [Related]
34. Novel immunomodulatory oligonucleotides prevent development of allergic airway inflammation and airway hyperresponsiveness in asthma.
Agrawal DK; Edwan J; Kandimalla ER; Yu D; Bhagat L; Wang D; Agrawal S
Int Immunopharmacol; 2004 Jan; 4(1):127-38. PubMed ID: 14975367
[TBL] [Abstract][Full Text] [Related]
35. Effect of chemical modifications of cytosine and guanine in a CpG-motif of oligonucleotides: structure-immunostimulatory activity relationships.
Kandimalla ER; Yu D; Zhao Q; Agrawal S
Bioorg Med Chem; 2001 Mar; 9(3):807-13. PubMed ID: 11310616
[TBL] [Abstract][Full Text] [Related]
36. Immune stimulation by a CpG-containing oligodeoxynucleotide is enhanced when encapsulated and delivered in lipid particles.
Mui B; Raney SG; Semple SC; Hope MJ
J Pharmacol Exp Ther; 2001 Sep; 298(3):1185-92. PubMed ID: 11504819
[TBL] [Abstract][Full Text] [Related]
37. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets.
Hemmi H; Kaisho T; Takeda K; Akira S
J Immunol; 2003 Mar; 170(6):3059-64. PubMed ID: 12626561
[TBL] [Abstract][Full Text] [Related]
38. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo.
Hartmann G; Weeratna RD; Ballas ZK; Payette P; Blackwell S; Suparto I; Rasmussen WL; Waldschmidt M; Sajuthi D; Purcell RH; Davis HL; Krieg AM
J Immunol; 2000 Feb; 164(3):1617-24. PubMed ID: 10640783
[TBL] [Abstract][Full Text] [Related]
39. P-chirality-dependent immune activation by phosphorothioate CpG oligodeoxynucleotides.
Krieg AM; Guga P; Stec W
Oligonucleotides; 2003; 13(6):491-9. PubMed ID: 15025915
[TBL] [Abstract][Full Text] [Related]
40. Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions.
Marshall JD; Fearon K; Abbate C; Subramanian S; Yee P; Gregorio J; Coffman RL; Van Nest G
J Leukoc Biol; 2003 Jun; 73(6):781-92. PubMed ID: 12773511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
